CBFB::MYH11 Inversion(16), Quantitative Detection and Minimal Disease Risk Monitoring, qRT-PCR, Varies | PULSE CLINIC - Asia's Leading Sexual Healthcare Network.
CBFB::MYH11 Inversion(16), Quantitative Detection and Minimal Disease Risk Monitoring, qRT-PCR, Varies

CBFB::MYH11 Inversion(16), Quantitative Detection and Minimal Disease Risk Monitoring, qRT-PCR, Varies

64

Overview

"CBFB::MYH11 Inversion(16), Quantitative Detection and Minimal Disease Risk Monitoring, qRT-PCR, Varies" refers to a molecular diagnostic approach aimed at detecting and quantifying a chromosomal inversion involving the CBFB and MYH11 genes in AML patients using qRT-PCR, with the purpose of assessing disease risk and monitoring minimal residual disease.


 

WHAT IS IT USED FOR?

Detecting the fusion of the CBFB and MYH11 genes in individuals newly diagnosed with acute myeloid leukemia (AML), and monitoring minimal residual disease throughout the clinical and therapeutic journey of AML patients.

 

METHOD NAME

Quantitative Real-Time Reverse Transcription Polymerase Chain Reaction (qRT-PCR)


AVAILABILITY

TBC

 

REPORTING NAME

Inv(16); CBFB-MYH11, Quant, V

 

OTHER NAMES

Inv(16)

T(16;16)

Inv(16)(p13.1q22)

T(16;16)(p13.1;q22)

CBFB-MYH11

AML M4 Eo

This site uses cookies to improve your experience. If you continue browsing, you accept our use of cookies. You can review our privacy & policy to find out more about the cookies we use.